Tags

Type your tag names separated by a space and hit enter

Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Am J Hematol. 2016 Mar; 91(3):E17-9.AJ

Authors+Show Affiliations

APHP, Department of Hemato-Oncology, Hopital Saint-Louis, Paris, France. Université Paris Diderot, Sorbonne Paris Cité, Paris, France.CHU Clermont-Ferrand, Service D'hématologie Clinique Adulte Et De Thérapie Cellulaire, Clermont-Ferrand, 63003, France. Clermont Université, Université D'auvergne, EA7283, CIC501, BP, , Clermont-Ferrand, 10448, 63000, France.APHP, Department of Pharmacology, Hopital Saint-Louis, Paris, France.Centre Hospitalier De Valenciennes, Service d'Hématologie-Immunologie-Cytogénétique, Valencia, France. Centre De Biologie Et Pathologie, Laboratoire D'hématologie, INSERM UMR 1172, IRCL, CHRU De Lille, Lille, France.APHP, Department of Hemato-Oncology, Hopital Saint-Louis, Paris, France. Université Paris Diderot, Sorbonne Paris Cité, Paris, France.CHU Clermont-Ferrand, Pôle De Radiologie, Clermont-Ferrand, 63003, France.Hématologie Biologique, Centre De Ressources Biologiques D'auvergne, CHU Clermont-Ferrand, Clermont-Ferrand, 63003, France.APHP, Department of Hemato-Oncology, Hopital Saint-Louis, Paris, France.APHP, Department of Radiology, Hopital Saint-Louis, Paris, France.CHU Clermont-Ferrand, Service D'hématologie Clinique Adulte Et De Thérapie Cellulaire, Clermont-Ferrand, 63003, France. Clermont Université, Université D'auvergne, EA7283, CIC501, BP, , Clermont-Ferrand, 10448, 63000, France.APHP, Department of Pharmacology, Hopital Saint-Louis, Paris, France.EA7324, Paris Descartes Université, Sorbonne Paris Cité, Paris, France.APHP, Department of Pharmacology, Hopital Saint-Louis, Paris, France.CHU Clermont-Ferrand, Service D'hématologie Clinique Adulte Et De Thérapie Cellulaire, Clermont-Ferrand, 63003, France. Clermont Université, Université D'auvergne, EA7283, CIC501, BP, , Clermont-Ferrand, 10448, 63000, France.APHP, Department of Hemato-Oncology, Hopital Saint-Louis, Paris, France. Université Paris Diderot, Sorbonne Paris Cité, Paris, France. EA7324, Paris Descartes Université, Sorbonne Paris Cité, Paris, France.

Pub Type(s)

Case Reports
Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26689870

Citation

Cabannes-Hamy, Aurélie, et al. "Efficacy of Ibrutinib in the Treatment of Bing-Neel Syndrome." American Journal of Hematology, vol. 91, no. 3, 2016, pp. E17-9.
Cabannes-Hamy A, Lemal R, Goldwirt L, et al. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome. Am J Hematol. 2016;91(3):E17-9.
Cabannes-Hamy, A., Lemal, R., Goldwirt, L., Poulain, S., Amorim, S., Pérignon, R., Berger, J., Brice, P., De Kerviler, E., Bay, J. O., Sauvageon, H., Beldjord, K., Mourah, S., Tournilhac, O., & Thieblemont, C. (2016). Efficacy of ibrutinib in the treatment of Bing-Neel syndrome. American Journal of Hematology, 91(3), E17-9. https://doi.org/10.1002/ajh.24279
Cabannes-Hamy A, et al. Efficacy of Ibrutinib in the Treatment of Bing-Neel Syndrome. Am J Hematol. 2016;91(3):E17-9. PubMed PMID: 26689870.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Efficacy of ibrutinib in the treatment of Bing-Neel syndrome. AU - Cabannes-Hamy,Aurélie, AU - Lemal,Richard, AU - Goldwirt,Lauriane, AU - Poulain,Stéphanie, AU - Amorim,Sandy, AU - Pérignon,Renan, AU - Berger,Juliette, AU - Brice,Pauline, AU - De Kerviler,Eric, AU - Bay,Jacques-Olivier, AU - Sauvageon,Helene, AU - Beldjord,Kheira, AU - Mourah,Samia, AU - Tournilhac,Olivier, AU - Thieblemont,Catherine, PY - 2015/12/14/received PY - 2015/12/15/accepted PY - 2015/12/23/entrez PY - 2015/12/23/pubmed PY - 2016/7/7/medline SP - E17 EP - 9 JF - American journal of hematology JO - Am. J. Hematol. VL - 91 IS - 3 SN - 1096-8652 UR - https://www.unboundmedicine.com/medline/citation/26689870/Efficacy_of_ibrutinib_in_the_treatment_of_Bing_Neel_syndrome_ L2 - https://doi.org/10.1002/ajh.24279 DB - PRIME DP - Unbound Medicine ER -